DBS for Epilepsy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 July 2024

  • curprev 10:3310:33, 26 July 2024‎ Fmichael1 talk contribs‎ 520 bytes +17‎ No edit summary
  • curprev 10:3110:31, 26 July 2024‎ Fmichael1 talk contribs‎ 503 bytes +503‎ Created page with "= SANTE TRIAL = ANT DBS for Epilepsy * First RCT - FDA approval in April 2018 * Sponsored by Medtronic * 157 patients enrolled, 110 implanted (2003-2007, 17 US centers) * Age 18-65 * Active 5V, cycling mode) vs. no stimulation during blinding (3 months) * 40.4% reduction in sz (active) vs. 14.5% reduction (control) (p=0.0017) * Side effects: paresthesia, memory decline, dizziness, implant site pain * Complications: infections (10/110) Category:Functional Neurosurgery..."
Retrieved from "https://www.fmichael1.com//wiki/index.php?title=DBS_for_Epilepsy"